Abstract
The burden of IE remained relatively high, characterized by a rising ASIR and a stable ASMR on a global scale. This burden was notably prominent among males, the elderly, and in the high and low SDI regions. Region-specific prevention and management strategies might be warranted to reduce the burden of IE.
Introduction
Infective endocarditis (IE) is a severe infection of the heart's inner lining or valves, carrying a high risk of morbidity and mortality. Historically, IE was frequently associated with rheumatic heart disease in younger populations. However, the epidemiological landscape is shifting. Today, it increasingly affects older adults, often linked to prosthetic valves, cardiac devices, and invasive medical procedures. Despite significant medical progress, one-year mortality rates for IE remain as high as 35%. This study utilizes the Global Burden of Disease (GBD) 2021 dataset to analyze global, regional, and national trends in IE from 1990 to 2021.
Methods and Data
This research is a secondary analysis of the GBD 2021 study, encompassing 204 countries and territories. The researchers utilized standardized ICD-9 and ICD-10 codes to identify IE cases from vital registration systems, verbal autopsies, hospital registries, and scientific literature.
Key metrics analyzed include absolute counts and age-standardized rates (ASR) for incidence (ASIR), mortality (ASMR), and disability-adjusted life years (ASDR). Trends were quantified using the Estimated Annual Percentage Change (EAPC), and Joinpoint regression was employed to identify significant shifts in these trends over time. Furthermore, the data was stratified by the Socio-demographic Index (SDI) to compare the disease burden across different levels of socioeconomic development.
Results and Discussion
The Demographic Shift to the Elderly
One of the most striking findings is the dramatic shift in the age distribution of IE. In 1990, the highest number of cases occurred in children under five years old. By 2021, the peak had shifted to the 65–69 age group. This transition reflects global population aging and the increased prevalence of predisposing factors in older adults, such as degenerative valve disease and the use of life-extending cardiac implants.
The SDI Paradox
The study reveals a distinct paradox based on socioeconomic development. High SDI regions exhibit the highest incidence (ASIR of 15.77 per 100,000) and the fastest growth in new cases, likely due to superior diagnostic capabilities and a higher frequency of medical interventions. Conversely, low SDI regions suffer from significantly higher mortality and disability rates (ASMR of 1.34 per 100,000), highlighting a critical "treatment gap" where patients lack access to early diagnosis and necessary surgical interventions.
Global Trends and Gender Disparity
Globally, incident cases of IE rose from 0.44 million in 1990 to 1.04 million in 2021, representing a 135% increase. While the ASIR grew by approximately 1.00% annually, the ASMR remained stable (EAPC 0.06), suggesting that the rise in deaths is primarily driven by population growth and aging rather than increased lethality. Additionally, males consistently bear a higher burden of IE than females, a disparity that has widened over the three-decade study period.
Prophylaxis and Guidelines
The analysis also addressed the ongoing debate regarding antibiotic prophylaxis before dental procedures. Joinpoint regression showed no sudden surge in global IE rates following the 2007 changes to major clinical guidelines, suggesting that rising incidence is driven by broader demographic and medical factors rather than changes in antibiotic policy.
Conclusion
While the global incidence of IE is rising, mortality rates have stabilized. The burden is increasingly concentrated among older males and varies significantly by socioeconomic status. Limitations of this study include the inability to distinguish between IE subtypes (e.g., native vs. prosthetic valve) and potential underdiagnosis in low-income regions. Future efforts should focus on improved screening for elderly patients with cardiac implants in high-income areas and strengthening healthcare infrastructure and surgical access in low-income regions.
Summary updated